BXN Insider Trading

Insider Ownership Percentage: 79.55%
Insider Buying (Last 12 Months): A$266,000.00
Insider Selling (Last 12 Months): A$0.00

Bioxyne Insider Trading History Chart

This chart shows the insider buying and selling history at Bioxyne by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Bioxyne Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 08/19/2019 01:00 AM ET

This chart shows the closing price history over time for BXN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Bioxyne Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/13/2023Samuel WatsonInsiderBuy20,000,000A$0.01A$260,000.00
10/6/2023Anthony (Tony) HoInsiderBuy500,000A$0.01A$6,000.00
6/30/2022Patrick FordInsiderTransfer1,000,000A$0.01A$12,000.00
3/21/2022Anthony (Tony) HoInsiderExpiry750,000A$0.02A$15,000.00
See Full Table

SEC Filings (Institutional Ownership Changes) for Bioxyne (ASX:BXN)

Bioxyne Limited, a life sciences and consumer health products company, manufactures and distributes consumer health products, patented probiotics, health supplements, therapeutic goods, and alternative medicines in the United Kingdom, Japan, Europe, and Australia. The company manufactures, commercializes, and distributes plant-based wellness products and supplements, including cannabinoids, cannabis extracts, vitamins, manuka honey, skin care products, and mushroom complexes. It develops various functional food products, such as ingredients; and lactobacillus fermentum VRI-003 for over-the counter gut health immune supplement products. The company also provides product research and development services, and telemedicine services. In addition, it operates BLS Clinics, a telehealth platform. The company provides its products online, as well as through wholesale and direct sales in the United States and Asia. Bioxyne Limited was incorporated in 1998 and is headquartered in Sydney, Australia.
Read More on Bioxyne

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

174,489 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

2.51%

Beta

0.7

Who are the company insiders with the largest holdings of Bioxyne?

Bioxyne's top insider shareholders include:
  1. Anthony (Tony) Ho (Insider)
  2. Samuel Watson (Insider)
Learn More about top insider investors at Bioxyne.